β-hydroxy-β-methylbutyrate (HMB)

DIETARY_SUPPLEMENT4 trials

Sponsors

University of Erlangen-Nürnberg Medical School, Universidad de Burgos, Duke University, Hospital de Clinicas de Porto Alegre

Conditions

AgingAmyotrophic Lateral Sclerosis ALSCancerCancer CachexiaFrailtyHeart FailureMalnutrition ElderlyMuscle Loss

Phase 1

Pilot Trial Utilizing β-hydroxy-β-methylbutyrate to Lower IGFBP7 Levels in People With ALS

Not yet recruitingNCT07589764

Duke UniversityAmyotrophic Lateral Sclerosis ALS

Start: 2026-10-01End: 2027-10-01Target: 100Updated: 2026-09-08

Unknown Phase

Effects of WB-EMS and Specific Dietary Supplements on Cancer Patients

University of Erlangen-Nürnberg Medical SchoolCancer, Cancer Cachexia, Weight Loss +2

Start: 2016-12-31End: 2019-04-30Target: 200Updated: 2018-10-16

Neuromuscular and Multi-Omics Synergy of Combined Creatine × HMB Supplementation Plus Exercise to Improve Muscle Function in Sarcopenic Frailty

Active, not recruitingNCT07275996

Universidad de BurgosFrailty, Sarcopenia, Aging +1

Start: 2026-03-10End: 2027-05-30Updated: 2026-05-04

High-Protein Diet and HMB Supplementation in Patients With Heart Failure

Not yet recruitingNCT07731048

Hospital de Clinicas de Porto AlegreHeart Failure

Start: 2026-09-01End: 2027-11-30Target: 84Updated: 2026-07-28